31 results on '"McColgan, Peter"'
Search Results
2. Plasma and CSF neurofilament light chain are stabilized in response to mutant huntingtin lowering in the brain of Huntington disease mice
3. Neuroimaging and plasma evidence of early white matter loss in Parkinson’s disease with poor outcomes
4. Changes in dynamic transitions between integrated and segregated states underlie visual hallucinations in Parkinson’s disease
5. NfL concentration in CSF is a quantitative marker of the rate of neurodegeneration in aging and Huntington's disease: a semi-mechanistic model-based analysis.
6. Modeling disease progression and placebo response in Huntington's Disease: Insights from Enroll-HD and GENERATION HD1 cohorts
7. Tominersen in Adults with Manifest Huntington’s Disease
8. Organisational and neuromodulatory underpinnings of structural-functional connectivity decoupling in patients with Parkinson’s disease
9. Neuroimaging and plasma marker evidence for white matter macrostructure loss in Parkinson’s disease
10. Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration
11. Quantitative MRI maps of human neocortex explored using cell type-specific gene expression analysis
12. Anti-amphiphysin associated paraneoplastic diencephalitis secondary to a thymic neuroendocrine tumour
13. J02 Quantitative analyses of pooled tominersen clinical data to support dose selection (rationale) for the new phase II study
14. J04 Benchmarking enroll-HD to a phase III placebo cohort from generation HD1 to inform clinical trial planning
15. E10 Cross-sectional exploration of the clinical utility of brain age as an imaging-based marker of disease pathology in Huntington’s disease (HD) based on the tominersen phase III trial generation HD 1
16. J03 Evaluating tominersen effect on self-reported quality of life (QoL) with high-frequency longitudinal, digital euroqol 5-dimensions 5-level (EQ-5D-5L) survey in generation HD1, a phase III trial of tominersen in adult individuals with manifest Huntington’s disease (HD)
17. E09 Quantitative MRI profiles across motor cortex cortical layers in premanifest Huntington’s disease using 7T MRI at 600μm resolution
18. Quantitative MRI maps of human neocortex explored using cell type-specific gene expression analysis.
19. Quantitative MRI maps of human neocortex explored using cell type-specific gene expression analysis
20. Neurofilament light-associated connectivity in young-adult Huntington’s disease is related to neuronal genes
21. 121 Autoimmune autonomic neuropathy on the Adie spectrum: ‘Ross syndrome?’
22. 128 White matter fibre loss in Parkinson’s disease hallucinations
23. 129 Network controllability and regional gene expression explain visual hallucinations in Parkinson’s
24. Visual dysfunction predicts cognitive impairment and white matter degenera- tion in Parkinson’s disease
25. Timing of selective basal ganglia white matter loss in premanifest Huntington’s disease
26. Longitudinal thalamic white and grey matter changes associated with visual hallucinations in Parkinson’s disease
27. F05 Biological and clinical characteristics of gene carriers far from predicted onset in the hd-yas study: a cross-sectional analysis
28. Longitudinal thalamic white and grey matter changes associated with visual hallucinations in Parkinson's disease.
29. Relating quantitative 7T MRI across cortical depths to cytoarchitectonics, gene expression and connectomics.
30. Concern about Tominersen in Patients with Huntington's Disease.
31. Erwiderung: Welchen Sinn hat die Einbeziehungskontrolle, wenn ihr Regelungszweck völlig verfehlt wird?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.